Entity Shareholding
From: | |
To: |
Ind | Shareholder | Virtual | Percentage | From | To | Scenario | Link & Description | |
---|---|---|---|---|---|---|---|---|
|
Borealis AG
|
100.00% | 03/2013 | 12/2050 | Statutory SH |
Royal DSM, the global Life Sciences and Materials Sciences company, announced today that it has completed the sale of its participation in DEXPlastomers to Borealis.
|
||
Total: |